Detalimogene Pivotal Cohort Durability Update

Company enGene Event Type Pivotal cohort data update (LEGEND) Modality Nonviral intravesical IL-12 gene therapy Asset Detalimogene voraplasmid Target Local IL-12 expression in bladder urothelium Disease Area BCG-unresponsive non-muscle-invasive bladder cancer Summary Source-gap reconciliation: enGene’s November 11 update of its single-arm pivotal LEGEND cohort reported…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *